Pe´ Smed VVS ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.2% 1.8% 2.6% 3.9% 1.6%  
Credit score (0-100)  84 72 59 50 73  
Credit rating  A A BBB BBB A  
Credit limit (kDKK)  98.6 1.7 0.0 0.0 8.2  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  4,375 4,327 5,322 6,147 7,508  
EBITDA  926 321 1,011 1,149 1,960  
EBIT  895 244 984 1,123 1,870  
Pre-tax profit (PTP)  852.6 197.0 946.0 1,073.0 1,823.0  
Net earnings  670.2 152.0 715.0 836.0 1,420.7  
Pre-tax profit without non-rec. items  853 197 946 1,073 1,823  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  65.1 9.0 3.0 235 217  
Shareholders equity total  1,759 1,800 915 1,251 2,072  
Interest-bearing liabilities  836 1,037 1,974 2,262 1,679  
Balance sheet total (assets)  4,558 4,904 4,853 6,192 6,511  

Net Debt  244 567 1,816 2,120 640  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  4,375 4,327 5,322 6,147 7,508  
Gross profit growth  23.1% -1.1% 23.0% 15.5% 22.1%  
Employees  0 9 9 11 12  
Employee growth %  0.0% 0.0% 0.0% 22.2% 9.1%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,558 4,904 4,853 6,192 6,511  
Balance sheet change%  23.0% 7.6% -1.0% 27.6% 5.2%  
Added value  925.7 321.0 1,011.0 1,150.0 1,959.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  28 -154 -54 184 -129  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  20.4% 5.6% 18.5% 18.3% 24.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  21.6% 5.2% 20.2% 20.3% 29.5%  
ROI %  38.9% 7.8% 29.8% 34.8% 51.2%  
ROE %  45.4% 8.5% 52.7% 77.2% 85.5%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  38.6% 36.7% 18.9% 20.2% 31.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  26.3% 176.6% 179.6% 184.5% 32.7%  
Gearing %  47.5% 57.6% 215.7% 180.8% 81.0%  
Net interest  0 0 0 0 0  
Financing costs %  5.1% 5.0% 2.5% 2.4% 2.4%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.1 1.6 1.7 1.2 1.5  
Current Ratio  1.6 2.1 2.4 1.7 1.9  
Cash and cash equivalent  592.0 470.0 158.0 142.0 1,038.5  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,543.6 2,517.0 2,754.0 2,481.0 3,011.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 36 112 105 163  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 36 112 104 163  
EBIT / employee  0 27 109 102 156  
Net earnings / employee  0 17 79 76 118